Note: These are AI-generated, educational summaries of public NSE
filings — grounded in each document, but not investment advice and possibly incomplete.
Verify against the original filing and consult a SEBI-registered adviser before acting.
Rs 2,500 Cr Investment: Deepak Nitrite to Set Up 240 KTA Bisphenol A Plant
Deepak Nitrite's subsidiary, Deepak Chem Tech Limited (DCTL), has approved a major investment of approximately Rs 2,500 crore to establish a Bisphenol A (BPA) manufacturing plant. The project features a capacity of up to 240 KTA and includes greenfield infrastructure. This investment is highly significant, representing roughly 31.7% of the company's TTM revenue and 77.8% of its current net worth. The move completes a strategic value chain from Phenol/Acetone to Polycarbonate, aiming to capture growth in the Indian Epoxy resin market and captive requirements.
high confidence
What changedDeepak Nitrite has formally committed to a large-scale downstream expansion into Bisphenol A, moving beyond its existing Phenolics business.
Why it mattersThis project creates a highly integrated chemical platform, reducing raw material risks for their upcoming Polycarbonate plant and entering the high-demand Epoxy resin market, which currently relies on imports.
Project Investment: Rs 2,500 CrCapacity: 240 KTAInvestment vs TTM Revenue: ~31.7%Investment vs Net Worth: ~77.8%Current Debt: Rs 60 Cr
📅 Short termThe market is likely to react positively to the scale of the expansion and the strategic move towards higher-value integrated products.
📈 Long termIf executed successfully, this transforms Deepak Nitrite into a dominant integrated player in the BPA-Polycarbonate chain, potentially improving long-term margins and market share.
⚠ Risk flags
Execution risk of a large-scale greenfield project
👀 What to Watch
Watch for the finalization of detailed engineering and the specific debt-equity funding mix, as this will significantly alter the company's leverage profile from its current near-debt-free status.
Deepak Nitrite Appoints Lohit Shringi as CEO for Advanced Intermediates Business
Deepak Nitrite has appointed Shri Lohit Shringi as the Chief Executive Officer for its Advanced Intermediates (AI) business, effective August 4, 2026. Shringi brings over 27 years of experience, having previously served as Executive Director and Chief of Specialty Chemicals at PCBL Chemical Limited. This leadership addition is strategic as the AI segment is currently undergoing both brownfield and greenfield expansions to deepen vertical integration. Given the company's TTM revenue of ‡7,887 Cr and current margin pressures from global dumping, this appointment aims to strengthen P&L management in a core growth area.
high confidence
What changedThe company has transitioned the leadership of its Advanced Intermediates business to a dedicated CEO with extensive specialty chemicals experience.
Why it mattersThe Advanced Intermediates segment is central to Deepak Nitrite's 'China+1' strategy and downstream integration; professional leadership is vital to navigate current global oversupply and pricing challenges.
📅 Short termThe market is likely to view the addition of a seasoned industry veteran from PCBL and DuPont as a positive step for operational stability.
📈 Long termShringi's experience in specialty chemicals and global markets is structurally significant for the company's move into high-value downstream products like MIBK and Polycarbonates.
⚠ Risk flags
Execution risk in ongoing greenfield projects
Global oversupply impacting AI segment margins
👀 What to Watch
Investors should monitor the execution of the AI segment's expansion projects and margin recovery in upcoming quarterly results under the new leadership.
Deepak Fertilizers Q1 FY27 Standalone PAT at ₹68.34 Cr; Tax Auditor Re-appointed
Deepak Fertilizers' board approved Q1 FY27 results and the re-appointment of M/s P G Bhagwat LLP as Tax Auditors for FY 2026-27. Standalone revenue for the quarter was ₹516.97 Cr, representing an 11.4% decline from ₹583.66 Cr in Q1 FY26. Standalone PAT also saw a contraction, falling 21.3% YoY to ₹68.34 Cr. The company continues its strategic focus on specialty products, which currently contribute 35% to fertilizer revenue.
high confidence
What changedThe company has formally approved its Q1 FY27 financial results and re-appointed its existing tax auditor for the new financial year.
Why it mattersThe standalone results show a year-on-year contraction in both revenue and profit, which may reflect the geopolitical headwinds and margin pressures previously flagged by management.
📅 Short termThe standalone earnings contraction might lead to neutral or slightly cautious sentiment in the immediate term until consolidated performance is fully assessed.
📈 Long termStructural growth remains tied to the shift toward high-margin specialty chemicals and the full capacity realization of new projects expected by FY 2029.
⚠ Risk flags
Margin pressure from geopolitical trade barriers
Dependency on global ammonia supply during Q4 shutdowns
👀 What to Watch
Investors should monitor the consolidated results to see if the specialty product mix (Croptek at 35% of fertilizer revenue) is successfully offsetting the margin pressure seen in the standalone figures.
101% YoY PAT Growth in Q1 FY27; ₹1,983 Cr Nitric Acid Project Commissioning in Q2
DEEPAKFERT reported a robust Q1 FY27 with PAT doubling YoY to ₹490 Cr, driven by a 22% revenue increase to ₹3,256 Cr. Operating EBITDA margins expanded significantly to 26.0% from 19.3% in the previous year, supported by global supply tightness and improved realizations in Mining Chemicals. The company is on the verge of commissioning its ₹1,983 Cr Nitric Acid project in Dahej during Q2 FY27, which will establish it as Asia's largest manufacturer. Despite a quarterly capex of ₹515 Cr, net debt reduced to ₹4,719 Cr, reflecting strong operational cash flows.
high confidence
What changedThe company has achieved a significant turnaround in profitability and margins, moving from a 12% EBITDA margin in Q4 FY26 to 26% in Q1 FY27, while nearing the completion of a major capex cycle.
Why it mattersThe doubling of profits and the imminent launch of Asia's largest Nitric Acid facility signal a transition toward higher-margin specialty products and market dominance in industrial chemicals.
Q1 FY27 PAT Growth (YoY): 101%Operating EBITDA Margin: 26.0%Dahej Project Capex: ₹1,983 CrCapex vs Net Worth: 54.1%Net Debt: ₹4,719 CrQ1 FY27 Revenue: ₹3,256 Cr
📅 Short termThe stock is likely to react positively to the sharp earnings beat and the clear timeline for the Dahej project commissioning.
📈 Long termThe structural shift from commodity to specialty chemicals (now 43% of fertilizer revenue) and massive capacity additions in Nitric Acid and TAN provide a strong multi-year growth trajectory.
⚠ Risk flags
Regulatory disruptions (PESO ANRS portal changes)
Geopolitical risks affecting raw material supply (RGP curtailment)
👀 What to Watch
Investors should monitor the successful commissioning and capacity ramp-up of the Dahej Nitric Acid project in Q2 FY27. Additionally, track the impact of monsoon progress on the Crop Nutrition segment's performance in the upcoming quarter.
Q1 Standalone Net Profit Drops 21% YoY to ₹68.34 Cr; Revenue Down 11%
Deepak Fertilizers reported a weak start to FY27 on a standalone basis, with revenue from operations declining 11.4% YoY to ₹516.97 Cr. Net profit followed suit, dropping 21.3% YoY to ₹68.34 Cr from ₹86.85 Cr in the year-ago period. Standalone EPS for the quarter contracted to ₹5.41 compared to ₹6.88 in Q1 FY26. The board also confirmed the re-appointment of M/s P G Bhagwat LLP as Tax Auditors for the 2026-27 fiscal year.
high confidence
What changedThe company released its Q1 FY27 financial results, marking a year-on-year decline in standalone top-line and bottom-line performance.
Why it mattersThe standalone results reflect the core manufacturing operations; a double-digit decline in profit suggests ongoing margin pressure or volume contraction in industrial chemicals and fertilizers, despite the company's strategic shift toward specialty products.
📅 Short termThe stock may face downward pressure in the short term as the market reacts to the YoY decline in standalone profitability.
📈 Long termThe long-term outlook remains tied to the successful ramp-up of specialty products (Croptek) and the realization of capacity from new projects by FY 2029, aiming for a 20% plus ROCE.
⚠ Risk flags
Margin contraction in standalone operations
Geopolitical headwinds affecting global chemical markets
Significant negative impact from cash flow hedges in the current quarter
👀 What to Watch
Investors should monitor the full consolidated results to assess if subsidiary performance mitigated the standalone decline. Key focus areas include the execution timeline for the Dahej and Gopalpur projects and the impact of global ammonia price volatility on margins.
₹120 Cr Investment in Deepak Chem Tech by Deepak Phenolics for Project Funding
Deepak Nitrite's subsidiary, Deepak Phenolics Limited (DPL), has invested ₹120 crore in another wholly-owned subsidiary, Deepak Chem Tech Limited (DCTL). The investment is made through 9% Optionally Convertible Redeemable Preference Shares (OCRPS) to support DCTL's project expenses and strengthen its capital base. DCTL is scaling rapidly, with its turnover increasing from ₹9.43 crore in FY25 to ₹172.23 crore in FY26. This internal capital reallocation supports the group's expansion into specialized segments like Fluorination and Nitric Acid.
high confidence
What changedDeepak Nitrite has moved ₹120 crore of capital from its Phenolics subsidiary to its Chem Tech subsidiary to fund ongoing specialized chemical projects.
Why it mattersThis demonstrates the company's strategy of using cash flows from its established Phenolics business to fund high-growth, downstream specialized chemical segments without external debt.
Investment Amount: ₹120.00 CroresDCTL FY26 Turnover: ₹172.23 CroresInvestment vs Net Worth: ~3.7%OCRPS Coupon Rate: 9%DCTL FY25 Turnover: ₹9.43 Crores
📅 Short termNeutral, as this is an intra-group transaction with no immediate impact on consolidated financial performance.
📈 Long termPositive, as it facilitates the expansion of DCTL's specialized chemical portfolio, which is central to the company's long-term 'China+1' and import substitution strategy.
⚠ Risk flags
Execution risk of ongoing projects within DCTL
Cyclicality and global dumping risks in the chemical sector
👀 What to Watch
Investors should monitor the operational ramp-up and margin profile of Deepak Chem Tech (DCTL) as it transitions from a project-phase entity to a meaningful revenue contributor.
$78.43 Million Corporate Guarantee Issued for Oman Subsidiary
Deepak Nitrite Limited has executed a Deed of Guarantee for US $78.43 million (approximately ₹655 crore) in favor of Bank Muscat SAOG. This guarantee secures a term loan for its 51% subsidiary, Deepak Oman Industries (SFZ) LLC (DOIL). The remaining 49% of DOIL is held by promoter entities, and the company will charge a guarantee commission for this service. This commitment represents a significant contingent liability, equivalent to approximately 20.4% of the company's current net worth.
high confidence
What changedDeepak Nitrite has formally committed to backing a $78.43M loan for its Oman-based subsidiary, creating a new contingent liability.
Why it mattersThis move facilitates capital for the company's international expansion in Oman but links the parent company's balance sheet to the subsidiary's financial performance.
Guarantee Amount: US $78.43 MillionSubsidiary Ownership: 51%Guarantee vs Net Worth: ~20.4%Guarantee vs TTM Revenue: ~8.3%Parent Net Worth: ₹3,215 Cr
📅 Short termThe market is likely to view this as a routine support for a subsidiary, though the size of the contingent liability may be noted by analysts.
📈 Long termThe structural impact depends on the successful execution and profitability of the Oman project; failure there could impact the parent's credit profile.
⚠ Risk flags
Contingent liability risk
Related-party involvement (Promoters hold 49% of the subsidiary)
👀 What to Watch
Investors should monitor the operational progress and debt-servicing capability of the Oman subsidiary to ensure the guarantee is not invoked.
Deepak Fertilizers Invests ₹5 Crore for 26% Stake in First Energy 11 for Captive Power
Deepak Fertilizers and Petrochemicals Corporation Limited has completed an investment of ₹5,00,00,000 in First Energy 11 Private Limited. The company has been allotted 50,00,000 equity shares, representing a minimum 26% stake (along with other captive users). This strategic move is intended for wind-solar hybrid power captive consumption to optimize energy costs under the Electricity Act, 2003. The shares were officially credited to the company's demat account on June 16, 2026.
Key Highlights
Invested ₹5,00,00,000 for the subscription of 50,00,000 equity shares at ₹10 each.Acquired a minimum 26% stake in First Energy 11 Private Limited for captive power purposes.The investment facilitates access to Wind-Solar Hybrid Power, aiming to reduce long-term energy costs.The transaction follows a Share Subscription and Shareholders Agreement (SSSA) originally signed on March 20, 2026.Shares were credited to the company's demat account on June 16, 2026, finalizing the investment process.
👀 What to Watch
Investors should view this as a positive step toward operational efficiency and ESG compliance; monitor future earnings for improvements in power and fuel cost margins.
Deepak Fertilizers Appoints Rajib Bhattacharjee as President - Transformation
Deepak Fertilizers and Petrochemicals Corporation Limited has appointed Mr. Rajib Bhattacharjee as President - Transformation, effective June 11, 2026. Mr. Bhattacharjee brings over 30 years of extensive experience in specialty chemicals and capital goods sectors. He joins from Galaxy Surfactants Ltd., where he served as Vice President – Global Specialties Chemicals Business, indicating a strategic hire from a major industry peer.
Key Highlights
Appointment of Mr. Rajib Bhattacharjee as President - Transformation effective June 11, 2026.Mr. Bhattacharjee possesses over 30 years of diverse industry experience in specialty chemicals and capital goods.Previously served as Vice President – Global Specialties Chemicals Business at Galaxy Surfactants Ltd.Holds a B.Tech in Chemical Engineering from NIT Trichy and an MBA in Marketing.Expertise includes strategic marketing, business development, and global P&L leadership.
👀 What to Watch
Investors should view this as a positive step in strengthening the leadership team with deep industry expertise. Monitor the company's progress in its transformation initiatives under the new leadership.
Deepak Fertilizers FY26 Revenue Up 12% to ₹11,506 Cr; Major Projects Near Completion
Deepak Fertilizers reported a 12% growth in annual revenue to ₹11,506 crore, despite a challenging Q4 impacted by a ₹75 crore one-off ammonia plant shutdown. The company is nearing the end of its major investment cycle, with the Gopalpur TAN and Dahej Nitric Acid projects being 95% and 86% complete, respectively. While margins in the fertilizer segment faced pressure from high input costs and subsidy lags, the Mining Chemicals business saw a strong 11% volume growth for the year. The commencement of a 15-year long-term LNG contract is expected to provide significant structural cost advantages moving forward.
Key Highlights
Full-year FY26 revenue reached ₹11,506 crore with an EBITDA of ₹1,684 crore.Gopalpur TAN project is 95% complete and Dahej Nitric Acid project is 86% complete, both expected to commission in Q2 FY27.Net debt stood at ₹4,824 crore with a Net Debt/EBITDA ratio of 2.86x as the company concludes its capex phase.Specialty and Croptek products increased their segment revenue contribution to 33% from 30% in the previous year.Mining Chemicals B2C segment scaled to 16% of revenue, reflecting a shift toward high-margin holistic solutions.
👀 What to Watch
Investors should focus on the timely commissioning of the Gopalpur and Dahej projects in Q2 FY27, which are critical for volume growth and margin expansion. While debt levels are elevated due to the investment cycle, the long-term LNG contract and backward integration into ammonia provide a strong competitive moat.
Deepak Nitrite Subsidiary DCTL Raises ₹120 Crore from Deepak Phenolics via OCRPS
Deepak Chem Tech Limited (DCTL), a wholly-owned subsidiary of Deepak Nitrite, has allotted 1.2 crore 9% Optionally Convertible Redeemable Preference Shares (OCRPS) to Deepak Phenolics Limited (DPL), another wholly-owned subsidiary. The transaction, valued at ₹120 crore, is aimed at strengthening DCTL's capital base and funding its ongoing project expenses. DCTL is currently scaling its operations in Fluorination and Nitration, with its turnover jumping significantly from ₹9.43 crore in FY25 to ₹172.23 crore in FY26. This internal capital reallocation allows the group to utilize surplus funds from DPL to fuel growth in DCTL.
Key Highlights
DCTL allotted 1,20,00,000 9% OCRPS at a face value of ₹100 each, totaling ₹120 crore.The investment was made by Deepak Phenolics Limited (DPL), a fellow wholly-owned subsidiary of Deepak Nitrite.DCTL's turnover showed exponential growth, reaching ₹172.23 crore in FY 2025-26 compared to just ₹9.43 crore in FY 2024-25.Funds will be utilized for project expenses across Fluorination, Nitric Acid, Nitration, and Hydrogenation plants in Gujarat.The transaction was conducted at arm's length and does not change the parent company's 100% control over the subsidiaries.
👀 What to Watch
Investors should view this as a routine internal capital management move; however, the rapid turnover growth in DCTL suggests that the subsidiary's new projects are gaining traction and should be monitored for future consolidated earnings impact.
Deepak Fertilisers Q4 FY26: Revenue Up 13% to ₹3,011 Cr, PAT Drops 50% on Margin Pressure
Deepak Fertilisers reported a 13% YoY revenue growth in Q4 FY26 to ₹3,011 Cr, though PAT halved to ₹139 Cr due to high raw material costs and a ₹75 Cr one-off maintenance shutdown. For the full year FY26, revenue reached ₹11,506 Cr (+12% YoY) while PAT declined 22% to ₹739 Cr. The company is transitioning to a specialty-led portfolio, with specialty products now contributing 33% of fertiliser revenue. Despite margin headwinds in the fertiliser segment due to inadequate subsidies, the company has commenced its 15-year LNG contract with Equinor to stabilize future input costs.
Key Highlights
Q4 FY26 Revenue grew 13% YoY to ₹3,011 Cr; Full year FY26 Revenue up 12% to ₹11,506 Cr.Q4 PAT declined 50% YoY to ₹139 Cr, impacted by a ₹75 Cr ammonia plant turnaround and high input costs.Board recommended a 100% dividend; Net Debt stands at ₹4,824 Cr with Net Debt/EBITDA at 2.86x.Major expansion projects at Gopalpur and Dahej delayed to Q2 FY27 due to labor and supply chain issues.Subsidiary DMSL completed the acquisition of Chardham Chemicals Private Limited to enhance mining services.
👀 What to Watch
Investors should monitor the margin recovery in FY27 as the 15-year LNG contract kicks in and the impact of the below-normal monsoon forecast. The delay in commissioning key projects to Q2 FY27 suggests a wait-and-watch approach for the next two quarters.
Deepak Fertilizers Recommends ₹10 Dividend per Share; Sets Record Date for August 25, 2026
Deepak Fertilizers has recommended a dividend of ₹10 per equity share for the financial year ended March 31, 2026, representing a 100% payout on the face value. The company has fixed Tuesday, August 25, 2026, as the record date to determine shareholder eligibility for this payment. The Board also approved the audited financial results for FY26 with an unmodified audit opinion, ensuring financial transparency. Additionally, the company announced leadership changes including the appointment of Mr. Yeshil S. Mehta as an Additional Director.
Key Highlights
Recommended a dividend of ₹10 per equity share for the financial year ended March 31, 2026.Fixed August 25, 2026, as the record date for dividend eligibility and payment.46th Annual General Meeting (AGM) scheduled for Tuesday, September 1, 2026.Statutory Auditors P G Bhagwat LLP re-appointed for a second five-year term.Mr. Yeshil S. Mehta appointed as Additional Director effective July 1, 2026.
👀 What to Watch
Investors should hold the stock until the record date of August 25, 2026, to qualify for the ₹10 dividend payout. The unmodified audit report and management continuity suggest stable corporate governance.
Deepak Fertilisers and Petrochemicals Corporation Limited (DFPCL) has recommended a dividend of ₹10 per equity share for FY26, representing a 100% payout on face value. The company announced a strategic management shift with CMD Sailesh C. Mehta taking charge of the subsidiary Deepak Mining Solutions while transitioning to a Non-Executive Chairman role at Mahadhan AgriTech. Additionally, Yeshil S. Mehta has been appointed as an Additional Director effective July 1, 2026. The company also confirmed an unmodified audit opinion for its FY26 financial results and re-appointed its statutory auditors for a second five-year term.
Key Highlights
Recommended a dividend of ₹10 per equity share for the financial year ended March 31, 2026.CMD Sailesh C. Mehta appointed as CMD of Deepak Mining Solutions Limited effective June 1, 2026.Appointment of Yeshil S. Mehta as Additional Director (Non-executive) effective July 1, 2026.Re-appointment of M/s P G Bhagwat LLP as Statutory Auditors for a second term of five years.Record date for dividend payment set for August 25, 2026, with the AGM scheduled for September 1, 2026.
👀 What to Watch
Investors should track the record date of August 25, 2026, to be eligible for the ₹10 dividend. The leadership transition suggests a strategic focus on the mining solutions subsidiary, which investors should monitor for future growth contributions.
CRISIL Reaffirms Deepak Fertilizers' 'AA-/Positive' Rating; Outlook Remains Strong
CRISIL has reaffirmed the long-term credit rating of Deepak Fertilizers at 'AA-' with a 'Positive' outlook, signaling potential for a future upgrade. The company's major expansion projects in Technical Ammonium Nitrate (TAN) and Nitric Acid are nearing completion (93% and 86% respectively) and are expected to drive growth from H2 FY2027. While net debt is projected to peak at Rs 4,800-5,200 crore in FY2026, leverage is expected to moderate to 2-2.2x by FY2027 as capex cycles end. A new long-term LNG contract with Equinor starting May 2026 is set to lower ammonia production costs, enhancing future margins.
Key Highlights
CRISIL AA-/Positive rating reaffirmed; bank loan facilities reduced to Rs 1,125 crore following partial withdrawal.TAN and Nitric Acid expansion projects are 93% and 86% complete respectively, targeting H2 FY2027 commissioning.9M FY26 revenue grew 19% YoY to Rs 8,495 crore, supported by strong demand across segments.Net leverage expected to peak at 2.8-3x in FY26 before declining to 2-2.2x in FY27 as accruals improve.New LNG supply contract with Equinor starting May 2026 will provide cheaper feedstock for ammonia production.
👀 What to Watch
Investors should maintain a positive stance as the 'Positive' outlook and nearing completion of major capex suggest a transition toward higher earnings and lower leverage. Monitor the timely commissioning of the TAN and Nitric Acid plants in late 2026 as key growth triggers.
Deepak Nitrite Q4 FY26 PAT Surges 120% QoQ to ₹220 Cr; ₹7.5 Dividend Recommended
Deepak Nitrite reported a strong sequential recovery in Q4 FY26, with consolidated PAT rising 120% QoQ to ₹220 crore and EBITDA margins expanding significantly to 18% from 11% in Q3. The Phenolics segment was a major driver, achieving 20% EBIT margins despite global supply chain disruptions in the Middle East. For the full year FY26, the company recorded revenues of ₹7,947 crore and a PAT of ₹551 crore. Management confirmed that strategic projects including MIBK, MIBC, and the polycarbonate facility are on track, with some commissioning expected in Q2 FY27.
Key Highlights
Q4 FY26 EBITDA grew 74% sequentially to ₹383 crore, with margins improving to 18% from 11% in Q3.Phenolics segment EBIT margins reached 20% in Q4, supported by stable plant operations and improving spreads.Advanced Intermediates revenue grew 8% YoY to ₹708 crore, driven by stable domestic demand in India.The Board recommended a final dividend of ₹7.5 per equity share for FY26.Strategic MIBK and MIBC projects are scheduled for commissioning in Q2 FY27, enhancing future growth visibility.
👀 What to Watch
Investors should view the sharp sequential margin recovery as a positive sign of operational resilience. Monitor the timely commissioning of the MIBK and MIBC projects in Q2 FY27 as they are expected to further diversify the value-added product portfolio.
Deepak Nitrite Q4 FY26 PAT Jumps 120% Q-o-Q to ₹220 Cr; EBITDA Up 74% Sequentially
Deepak Nitrite reported a strong sequential recovery in Q4 FY26, with PAT rising 120% Q-o-Q to ₹220 crore and EBITDA growing 74% to ₹383 crore. While the full-year FY26 performance saw a 21% decline in PAT to ₹551 crore due to global pricing pressures, the quarterly momentum indicates a sharp turnaround in margins. The Phenolics segment delivered robust performance with a 97% Q-o-Q EBIT growth, supported by record production volumes. The company is also making significant progress on its Polycarbonate project and has established a new ₹100 crore R&D center to drive future growth.
Key Highlights
Q4 FY26 EBITDA grew 74% Q-o-Q to ₹383 crore, driven by proactive procurement and backward integration benefits.Phenolics segment EBIT rose 97% Q-o-Q to ₹287 crore, achieving highest-ever production and sales in FY26.Advanced Intermediates segment EBIT surged 125% Q-o-Q to ₹34 crore, aided by a favorable product mix.Polycarbonate project on track with equipment shipments from Germany and a long-term HyCO plant agreement with Linde.Maintained a strong dividend payout of 375% for FY26, including special and final dividends.
👀 What to Watch
Investors should take note of the significant sequential margin expansion and the company's successful navigation of global supply chain disruptions. The progress on the Polycarbonate project and the new R&D facility strengthen the long-term growth thesis for this chemical major.
Deepak Nitrite Appoints Anant Pande as ED & CMO; Re-appoints Girish Satarkar for 3 Years
Deepak Nitrite has announced a significant leadership transition with the appointment of Shri Anant Pande as Executive Director and Chief Manufacturing Officer for a three-year term starting August 5, 2026. Mr. Pande brings 40 years of extensive experience from leadership roles at Jubilant Life Sciences and Atul Limited. Concurrently, the board has approved the re-appointment of Shri Girish Satarkar as Executive Director for another three-year term. These changes come as Shri Ajay C. Mehta prepares to retire from the board at the upcoming Annual General Meeting.
Key Highlights
Shri Anant Pande appointed as Executive Director & Chief Manufacturing Officer for a 3-year term starting August 5, 2026Shri Girish Satarkar re-appointed as Executive Director for a 3-year term effective August 4, 2026Shri Ajay C. Mehta to retire from the Board at the ensuing AGM after not seeking re-appointmentNew appointee Anant Pande has 40 years of experience in life sciences, chemicals, and pharmaceuticalsGirish Satarkar brings over 37 years of chemical industry experience to his continued role
👀 What to Watch
This is a routine succession and leadership strengthening move. Investors should monitor if the new Chief Manufacturing Officer introduces any operational efficiencies in the upcoming quarters.
Deepak Nitrite Recommends Final Dividend of ₹7.50 Per Share (375%) for FY2026
The Board of Directors of Deepak Nitrite Limited has recommended a final dividend of ₹7.50 per equity share for the financial year ended March 31, 2026. This represents a significant 375% payout on the face value of ₹2 per share. The dividend is applicable to over 13.63 crore equity shares and is subject to shareholder approval at the upcoming 55th Annual General Meeting. Upon approval, the payment will be processed within 30 days of the AGM date.
Key Highlights
Recommended final dividend of ₹7.50 per equity share for the year ended March 31, 2026Dividend payout represents 375% of the face value of ₹2 per shareTotal number of equity shares eligible for dividend stands at 13,63,93,041Payment to be completed within 30 days from the date of the 55th Annual General Meeting
👀 What to Watch
Investors should monitor the announcement of the record date to ensure eligibility for the dividend. The healthy payout reflects the company's strong cash position and commitment to shareholder returns.
Deepak Nitrite Q4 FY26 Net Profit Jumps 103% YoY to ₹202.5 Cr Despite Annual Revenue Dip
Deepak Nitrite reported a strong recovery in Q4 FY26 with consolidated net profit doubling to ₹202.50 crore compared to ₹99.82 crore in the same quarter last year. For the full year FY26, consolidated revenue stood at ₹7,887.07 crore, a 4.8% decline from ₹8,281.93 crore in FY25, primarily due to lower realizations in the Phenolics segment. Annual net profit for FY26 settled at ₹610.21 crore, down from ₹697.37 crore in the previous year. Despite the annual decline, the sharp quarterly growth indicates significant margin improvement and operational recovery in the latter half of the year.
Key Highlights
Q4 FY26 Consolidated Net Profit surged 102.8% YoY to ₹202.50 crore.Full-year FY26 Consolidated Revenue from operations stood at ₹7,887.07 crore vs ₹8,281.93 crore in FY25.Phenolics segment revenue for FY26 decreased to ₹5,400.68 crore from ₹5,805.10 crore YoY.Advanced Intermediates segment revenue remained resilient at ₹2,553.32 crore for FY26.Consolidated Total Assets grew to ₹8,680.68 crore as of March 31, 2026, from ₹7,717.57 crore in the previous year.
👀 What to Watch
Investors should view the strong Q4 performance as a sign of cyclical recovery and margin expansion. While annual figures are lower, the sequential and YoY quarterly growth suggests the company is navigating pricing pressures effectively.
⚠️How this site is made: Market data pages are computed automatically from NSE/BSE publications and company filings; news articles and announcement analyses are written with AI assistance, with a human in the loop: our editors review what the AI produces. Both can contain errors. Verify with the original sources before any investment decision. Not investment advice; Flash Finance is not SEBI-registered. How we use AI
🎁 Limited-time offer for early supporters
Our AI stock analytics, free on Telegram & WhatsApp
⚡ We track 3500+ companies instantly. As soon as a filing hits the NSE exchange, our AI reads it, summarizes it and tells you the impact in seconds.
Paid platforms charge ₹1,00,000+ a year for AI analytics like this. Join our channels and get it free.